Published 13 hours ago • loading... • Updated 13 hours agoShow Less IconMcDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to Wait McDonald’s wins on growth and dividend safety, while Pfizer offers a higher 7.1% yield but faces falling revenue and a flat payout.Summary by 247wallst.comBoth McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise retirees a place to park serious money. But one of them carries hidden risks that could quietly wreck an income portfolio.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort Icon247wallst.comCenterFactualityOwnershipMcDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to WaitBoth McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise retirees a place to park serious money. But one of them carries hidden risks that could quietly wreck an income portfolio.13 hours ago·New York, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated13 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to Vantage247wallst.com broke the news in New York, United States 13 hours ago on Friday, July 10, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsMcDonald's Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsMcDonald's Plus IconShow All